M Holdings Securities, Inc. Geron Corp Transaction History

M Holdings Securities, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 17, 2019	SELL	$1.01 - $1.83 $83,476 - $151,249	-82,650 Closed	0 $0
Q3 2018 Nov 16, 2018	BUY	$1.76 - $6.38 $101,464 - $367,807	57,650 Added 230.6%	82,650 $145,000
Q2 2018 Aug 17, 2018	SELL	$3.29 - $4.82 $321,679 - $471,275	-97,775 Reduced 79.64%	25,000 $86,000
Q1 2018 May 18, 2018	BUY	$1.81 - $5.98 $222,222 - $734,194	122,775 New	122,775 $522,000

275

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.51B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of M Holdings Securities, Inc., based on Form 13F filings with the SEC.

Stay updated on M Holdings Securities, Inc. with notifications on news.